UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The EANM practice guidelines for parathyroid imaging

European journal of nuclear medicine and molecular imaging, 2021-08, Vol.48 (9), p.2801-2822

2021

Volltextzugriff (PDF)

68Ga-PSMA-11 PET/CT in restaging castration-resistant nonmetastatic prostate cancer: detection rate, impact on patients’ disease management and adequacy of impact

Scientific reports, 2020-02, Vol.10 (1), p.2104-2104, Article 2104

2020

Volltextzugriff (PDF)

Hepatocellular Carcinomas With Mutational Activation of Beta-Catenin Require Choline and Can Be Detected by Positron Emission Tomography

Gastroenterology (New York, N.Y. 1943), 2019-09, Vol.157 (3), p.807-822

2019

Volltextzugriff (PDF)

Liposomes for PET and MR Imaging and for Dual Targeting (Magnetic Field/Glucose Moiety): Synthesis, Properties, and in Vivo Studies

Molecular pharmaceutics, 2017-02, Vol.14 (2), p.406-414

2017

Volltextzugriff (PDF)

An essential practice summary of the new EANM guidelines for parathyroid imaging

The quarterly journal of nuclear medicine and molecular imaging, 2022-06, Vol.66 (2), p.93

2022

Volltextzugriff (PDF)

[68Ga]RGD Versus [18F]FDG PET Imaging in Monitoring Treatment Response of a Mouse Model of Human Glioblastoma Tumor with Bevacizumab and/or Temozolomide

Molecular imaging and biology, 2019-04, Vol.21 (2), p.297-305

2019

Volltextzugriff (PDF)

A comparative study of peptide-based imaging agents [68Ga]Ga-PSMA-11, [68Ga]Ga-AMBA, [68Ga]Ga-NODAGA-RGD and [68Ga]Ga-DOTA-NT-20.3 in preclinical prostate tumour models

Nuclear medicine and biology, 2020-05, Vol.84-85, p.88-95

2020

Volltextzugriff (PDF)

18F-fluorocholine PET/CT in MEN1 Patients with Primary Hyperparathyroidism

World journal of surgery, 2020-11, Vol.44 (11), p.3761-3769

2020

Volltextzugriff (PDF)

Fully automated radiolabeling of [68Ga]Ga-EMP100 targeting c-MET for PET-CT clinical imaging

EJNMMI radiopharmacy and chemistry, 2023-10, Vol.8 (1), p.30-30, Article 30

2023

Volltextzugriff (PDF)

Current evaluation of the clinical utility of Fluoromethylcholine-(18F) PET/CT in Prostate Cancer

Brazilian Archives of Biology and Technology, 2008-12, Vol.51 (spe), p.71-75

2008

Volltextzugriff (PDF)

Novel DOTA-Neurotensin Analogues for 111In Scintigraphy and 68Ga PET Imaging of Neurotensin Receptor-Positive Tumors

Bioconjugate chemistry, 2011-07, Vol.22 (7), p.1374-1385

2011

Volltextzugriff (PDF)

Equivalent Dose Rate 1 Meter from Neuroendocrine Tumor Patients Exiting the Nuclear Medicine Department After Undergoing Imaging

Journal of Nuclear Medicine, 2017-08, Vol.58 (8), p.1230-1235

2017

Volltextzugriff (PDF)

Impact of Fluorodihydroxyphenylalanine-(18F) Positron Emission Tomography on Management of Adult Patients with Documented or Occult Digestive Endocrine Tumors

The journal of clinical endocrinology and metabolism, 2009-04, Vol.94 (4), p.1295-1301

2009

Volltextzugriff (PDF)

Incidental uptake of 18F-fluorocholine (FCH) in the head or in the neck of patients with prostate cancer

Radiology and oncology, 2014-09, Vol.48 (3), p.228-234

2014

Volltextzugriff (PDF)

Comparison of Normocalcemic vs Hypercalcemic Primary Hyperparathyroidism in a Hypercalciuric Renal Stone Population

The journal of clinical endocrinology and metabolism, 2024-09, Vol.109 (10), p.2553-2560

2024

Volltextzugriff (PDF)

Nuclear medicine innovations help (drive) healthcare (benefits)

European journal of nuclear medicine and molecular imaging, 2015-02, Vol.42 (2), p.173-175

2015

Volltextzugriff (PDF)

Response to the letter to the Editor by Professors Francesco Giammarile and Stefano Fanti regarding our article “Survey by the ANSM of the imaging protocol, detection rate, and safety of 68Ga-PSMA-11 PET/CT”

European journal of nuclear medicine and molecular imaging, 2021-08, Vol.48 (9), p.2692-2695

2021

Volltextzugriff (PDF)

Interference of Known or Suspected Endometriosis in Reporting FDG PET/CT Performed in Another Indication

Clinical nuclear medicine, 2022-04, Vol.47 (4), p.305-313

2022

Volltextzugriff (PDF)

Comparison of normocalcemic versus hypercalcemic primary hyperparathyroidism in a hypercalciuric renal stone population

The journal of clinical endocrinology and metabolism, 2024-03

2024

Volltextzugriff (PDF)

The Presence of an Arteria Lusoria Should Be Checked When Reporting 18F-FCH PET/CT Performed to Localize Hyperfunctioning Parathyroid Glands

Clinical nuclear medicine, 2023-11, Vol.48 (11), p.958-959

2023

Volltextzugriff (PDF)

Fluorine-18 Fluorodeoxyglucose with Positron Emission Tomography Revealed Bone Marrow Involvement in Sarcoidosis Patients with Anaemia

Respiration, 2010-01, Vol.79 (1), p.25-31

2010

Volltextzugriff (PDF)

Evaluation of fluorodeoxyglucose positron emission tomography in the detection of axillary lymph node metastases in patients with early-stage breast cancer

Annals of surgical oncology, 2003-07, Vol.10 (6), p.622-627

2003

Volltextzugriff (PDF)

Consequence of the introduction of routine FCH PET/CT imaging for patients with prostate cancer: a dual centre survey

Radiology and oncology, 2014-03, Vol.48 (1), p.20-28

2014

Volltextzugriff (PDF)

Use of choline PET for studying hepatocellular carcinoma

Clinical and translational imaging : reviews in nuclear medicine and molecular imaging, 2014-04, Vol.2 (2), p.103-113

2014

Volltextzugriff (PDF)

Designing clinical trials based on modern imaging and metastasis-directed treatments in patients with oligometastatic breast cancer: a consensus recommendation from the EORTC Imaging and Breast Cancer Groups

The lancet oncology, 2023-08, Vol.24 (8), p.e331-e343

2023

Volltextzugriff (PDF)

1 – 25 von 154

Suche als RSS-Feed

Aktive Filter

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(143)
Mit Volltextzugriff
(133)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(47)
Life Sciences & Biomedicine
(45)
Humans
(40)
Fluorodeoxyglucose F18
(24)
Radiopharmaceuticals
(23)
Life Sciences
(20)
Female
(19)
Nuclear Medicine
(19)
Radiology, Nuclear Medicine & Medical Imaging
(19)
Positron-Emission Tomography
(17)
Imaging
(16)
Oncology
(16)
Medicine
(15)
Medicine & Public Health
(15)
Radiology
(15)
Tomography
(15)
Medical Imaging
(13)
Positron Emission
(12)
Sciences Biologiques Et Medicales
(12)
Sciences Medicales
(12)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

The EANM practice guidelines for parathyroid imaging

68Ga-PSMA-11 PET/CT in restaging castration-resistant nonmetastatic prostate cancer: detection rate, impact on patients’ disease management and adequacy of impact

Hepatocellular Carcinomas With Mutational Activation of Beta-Catenin Require Choline and Can Be Detected by Positron Emission Tomography

Liposomes for PET and MR Imaging and for Dual Targeting (Magnetic Field/Glucose Moiety): Synthesis, Properties, and in Vivo Studies

An essential practice summary of the new EANM guidelines for parathyroid imaging

[68Ga]RGD Versus [18F]FDG PET Imaging in Monitoring Treatment Response of a Mouse Model of Human Glioblastoma Tumor with Bevacizumab and/or Temozolomide

A comparative study of peptide-based imaging agents [68Ga]Ga-PSMA-11, [68Ga]Ga-AMBA, [68Ga]Ga-NODAGA-RGD and [68Ga]Ga-DOTA-NT-20.3 in preclinical prostate tumour models

18F-fluorocholine PET/CT in MEN1 Patients with Primary Hyperparathyroidism

Fully automated radiolabeling of [68Ga]Ga-EMP100 targeting c-MET for PET-CT clinical imaging

Current evaluation of the clinical utility of Fluoromethylcholine-(18F) PET/CT in Prostate Cancer

Novel DOTA-Neurotensin Analogues for 111In Scintigraphy and 68Ga PET Imaging of Neurotensin Receptor-Positive Tumors

Equivalent Dose Rate 1 Meter from Neuroendocrine Tumor Patients Exiting the Nuclear Medicine Department After Undergoing Imaging

Impact of Fluorodihydroxyphenylalanine-(18F) Positron Emission Tomography on Management of Adult Patients with Documented or Occult Digestive Endocrine Tumors

Incidental uptake of 18F-fluorocholine (FCH) in the head or in the neck of patients with prostate cancer

Comparison of Normocalcemic vs Hypercalcemic Primary Hyperparathyroidism in a Hypercalciuric Renal Stone Population

Nuclear medicine innovations help (drive) healthcare (benefits)

Response to the letter to the Editor by Professors Francesco Giammarile and Stefano Fanti regarding our article “Survey by the ANSM of the imaging protocol, detection rate, and safety of 68Ga-PSMA-11 PET/CT”

Interference of Known or Suspected Endometriosis in Reporting FDG PET/CT Performed in Another Indication

Comparison of normocalcemic versus hypercalcemic primary hyperparathyroidism in a hypercalciuric renal stone population

The Presence of an Arteria Lusoria Should Be Checked When Reporting 18F-FCH PET/CT Performed to Localize Hyperfunctioning Parathyroid Glands

Fluorine-18 Fluorodeoxyglucose with Positron Emission Tomography Revealed Bone Marrow Involvement in Sarcoidosis Patients with Anaemia

Evaluation of fluorodeoxyglucose positron emission tomography in the detection of axillary lymph node metastases in patients with early-stage breast cancer

Consequence of the introduction of routine FCH PET/CT imaging for patients with prostate cancer: a dual centre survey

Use of choline PET for studying hepatocellular carcinoma

Designing clinical trials based on modern imaging and metastasis-directed treatments in patients with oligometastatic breast cancer: a consensus recommendation from the EORTC Imaging and Breast Cancer Groups

Aktive Filter

Suchergebnisse filtern